Literature DB >> 3473354

Hyperbaric oxygen in the treatment of osteoradionecrosis: a review of its use and efficacy.

L Fattore, R A Strauss.   

Abstract

Hyperbaric oxygen (HBO) therapy is an established technology that is proving to be effective in the treatment of osteoradionecrosis. However, the studies that have shown this treatment modality to be effective have not established the optimum pressures, times of exposure, and frequency and number of treatment necessary for healing. In addition, most of the studies used HBO as an adjunctive treatment in the management of refractory osteoradionecrosis. The efficacy of HBO as a primary treatment modality has not as yet been established. Strictly controlled clinical trials are necessary for identification of patients who are likely to respond to HBO without aggressive surgery, to delineate a timetable for treatment of patients with HBO, and to coordinate surgery with HBO to resolve osteoradionecrosis when a significant amount of bone loss is involved.

Entities:  

Mesh:

Year:  1987        PMID: 3473354     DOI: 10.1016/0030-4220(87)90190-3

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  3 in total

1.  A retrospective study of outcomes in subjects of head and neck cancer treated with hyperbaric oxygen therapy for radiation induced osteoradionecrosis of mandible at a tertiary care centre: an Indian experience.

Authors:  Puneet Gupta; Tarun Sahni; G K Jadhav; Sapna Manocha; Shweta Aggarwal; Sapna Verma
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-03-31

2.  Vascularized tissue transfer for closure of irradiated wounds after soft tissue sarcoma resection.

Authors:  W J Barwick; J A Goldberg; S P Scully; J M Harrelson
Journal:  Ann Surg       Date:  1992-11       Impact factor: 12.969

3.  A case of mandible osteonecrosis after a severe periimplant infection.

Authors:  Francesco Grecchi; Ilaria Zollino; Valentina Candotto; Francesco Gallo; Giuseppe Rubino; Sara Giglio; Raffaella Bianco; Francesco Carinci
Journal:  Dent Res J (Isfahan)       Date:  2012-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.